In conclusion, emerging evidence highlights that several genetic polymorphisms implicated in serotoninergic and dopaminergic neurotransmission and metabolism and neurotrophic factors, especially BDNF, circadian rhythm, and the endocannabinoid system, may affect depression risk in PD (Table 1). The gene discussed is BDNF; the disease is depressive disorder.